Novartis Healthcare A/S secures contract for Pharmaceutical products Framework agreement for the purchase of Kymriah tisagenlecleucel

Denmark, March 18 -- Denmark based Novartis Healthcare A/S has secured contract from Amgros I/S for Pharmaceutical products Framework agreement for the purchase of Kymriah tisagenlecleucel. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....